Ladenburg Thalmann update report - Head and Neck Cancer and Colorectal Studies To Expand Market Opportunity, Potentially As Early as 2014. Reiterate Buy Rating and $7.50 PT.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.